Squibb Company (NYSE:BMY) and Pfizer
Inc. (NYSE:PFE) today announced that the European Commission has
approved Eliquis for the treatment of DVT and PE, and the
prevention of recurrent DVT and PE in adults.
for European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE investment picks